British researchers have developed an experimental colorectal cancer vaccine that is showing promise in clinical trials.
The vaccine was created from antibodies cloned from a patient with advanced colorectal cancer who survived many years longer than expected. When given to 67 colorectal cancer patients (average age 66), the vaccine stimulated immune responses in 70 percent, researchers say.

del.icio.us
Digg this







